MicroRNA (miRNA) expression profiles for lung cancers were examined to investigate
miRNA's involvement in lung carcinogenesis. miRNA microarray analysis identified statistical …

In the neurological mutant mouse reeler, the histological organization of the neocortex develops
abnormally and essentially results in an inversion of the relative positions of the cortical …

Fifteen percent of lung cancer cases occur in never-smokers and show characteristics that are
molecularly and clinically distinct from those in smokers. Epidermal growth factor receptor (…

Background Dual blockade of the EGFR and VEGF pathways in EGFR-mutated metastatic
non-small-cell lung cancer (NSCLC) is supported by preclinical and clinical data, yet the …

Epithelial–mesenchymal transition (EMT) has recently been recognized as a key element of
cell invasion, migration, metastasis, and drug resistance in several types of cancer, …

Transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT) has
been shown to be related to the pathogenesis of various diseases including lung cancer. …

Background Bevacizumab is a promising candidate for combination treatment with epidermal
growth factor receptor tyrosine-kinase inhibitors (eg, erlotinib), which could improve …

BACKGROUND: Idiopathic interstitial pneumonias (IIPs) are one of the most common
complications in patients with lung cancer. In lung cancer patients with IIP, the most serious toxicity …

Background A 17-cytokine gene expression signature in noncancerous hepatic tissue from
patients with metastatic hepatocellular carcinoma (HCC) was recently found to predict HCC …

To ascertain the potential for histone deacetylase (HDAC) inhibitor-based treatment in non-small
cell lung cancer (NSCLC), we analyzed the antitumor effects of trichostatin A (TSA) and …